Ken‐Ichi Imadome

2.1k total citations
103 papers, 1.4k citations indexed

About

Ken‐Ichi Imadome is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ken‐Ichi Imadome has authored 103 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 39 papers in Immunology and 30 papers in Pathology and Forensic Medicine. Recurrent topics in Ken‐Ichi Imadome's work include Viral-associated cancers and disorders (71 papers), Immune Cell Function and Interaction (33 papers) and Lymphoma Diagnosis and Treatment (30 papers). Ken‐Ichi Imadome is often cited by papers focused on Viral-associated cancers and disorders (71 papers), Immune Cell Function and Interaction (33 papers) and Lymphoma Diagnosis and Treatment (30 papers). Ken‐Ichi Imadome collaborates with scholars based in Japan, United States and Sri Lanka. Ken‐Ichi Imadome's co-authors include Shigeyoshi Fujiwara, Norio Shimizu, Ayako Arai, Osamu Miura, Hiroyuki Nakamura, Misako Yajima, Naoki Yamamoto, Mamoru Ito, Masaki Shirakata and Takatoshi Koyama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Ken‐Ichi Imadome

94 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken‐Ichi Imadome Japan	22	859	606	409	330	202	103	1.4k
Noémi Nagy Sweden	24	867 1.0×	787 1.3×	451 1.1×	285 0.9×	189 0.9×	71	1.8k
Heather M. Long United Kingdom	24	1.2k 1.4×	902 1.5×	553 1.4×	596 1.8×	270 1.3×	37	1.8k
Blake Tomkinson United States	20	1.3k 1.5×	500 0.8×	609 1.5×	525 1.6×	368 1.8×	31	1.9k
David Ghez France	21	395 0.5×	541 0.9×	327 0.8×	247 0.7×	251 1.2×	81	1.4k
Misako Yajima Japan	15	566 0.7×	458 0.8×	223 0.5×	365 1.1×	151 0.7×	25	1.1k
Pauline Meij Netherlands	21	782 0.9×	500 0.8×	214 0.5×	381 1.2×	168 0.8×	48	1.3k
Yoshihiro Yakushijin Japan	23	766 0.9×	493 0.8×	421 1.0×	322 1.0×	78 0.4×	87	1.6k
Claire Shannon‐Lowe United Kingdom	27	1.7k 1.9×	830 1.4×	791 1.9×	696 2.1×	272 1.3×	36	2.3k
Andreas Moosmann Germany	24	1.3k 1.5×	1.0k 1.7×	302 0.7×	830 2.5×	197 1.0×	54	2.1k
Masakatsu Hishizawa Japan	20	542 0.6×	758 1.3×	294 0.7×	171 0.5×	63 0.3×	70	1.6k

Countries citing papers authored by Ken‐Ichi Imadome

Since Specialization

Citations

This map shows the geographic impact of Ken‐Ichi Imadome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐Ichi Imadome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐Ichi Imadome more than expected).

Fields of papers citing papers by Ken‐Ichi Imadome

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐Ichi Imadome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐Ichi Imadome. The network helps show where Ken‐Ichi Imadome may publish in the future.

Co-authorship network of co-authors of Ken‐Ichi Imadome

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐Ichi Imadome. A scholar is included among the top collaborators of Ken‐Ichi Imadome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐Ichi Imadome. Ken‐Ichi Imadome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsuo, Kosuke, et al.. (2025). A case of acute myeloid leukemia with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis successfully treated by cord blood transplantation. Journal of Infection and Chemotherapy. 31(8). 102767–102767.

Ono, Rintaro, Miyuki Tanaka, Ken‐Ichi Imadome, et al.. (2023). Cytokine‐based disease monitoring in refractory HLH with primary EBV infection. Pediatrics International. 65(1). e15590–e15590.

Imadome, Ken‐Ichi, et al.. (2023). A successful treatment for chronic active Epstein-Barr virus disease with Nephrotic Syndrome. CEN Case Reports. 13(3). 145–148.

Yamada, Masaki, Akinari Fukuda, Seiichi Shimizu, et al.. (2022). Early Detection of Epstein-Barr Virus as a Risk Factor for Chronic High Epstein-Barr Viral Load Carriage at a Living-donor–dominant Pediatric Liver Transplantation Center. Transplantation. 107(6). 1322–1329. 5 indexed citations

Matsubara, Etsuro, Kuniko Takano, Ken‐Ichi Imadome, et al.. (2022). A case of orofacial swelling accompanied by sarcoid-like reaction due to chronic active Epstein-Barr virus infection. European Journal of Dermatology. 32(2). 277–278.

Shimizu, Seiichi, Seisuke Sakamoto, Masaki Yamada, et al.. (2021). Immunological features and complications in patients with glycogen storage disease 1b after living donor liver transplantation. Pediatric Transplantation. 25(8). e14104–e14104. 4 indexed citations

Takei, Masami, Mitsuhiro Iwata, Yasuko Nagatsuka, et al.. (2021). Human osteoclastogenesis in Epstein-Barr virus-induced erosive arthritis in humanized NOD/Shi-scid/IL-2Rγnull mice. PLoS ONE. 16(4). e0249340–e0249340. 6 indexed citations

Yamada, Masaki, Seisuke Sakamoto, Kenichi Sakamoto, et al.. (2020). Fatal Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis with virus‐infected T cells after pediatric multivisceral transplantation: A proof‐of‐concept case report. Pediatric Transplantation. 25(3). e13961–e13961. 3 indexed citations

Imadome, Ken‐Ichi, Tohru Kobayashi, Masahide Yamamoto, et al.. (2020). Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Advances. 4(13). 2918–2926. 53 indexed citations

10.

Sakata, Naoki, Ai Tanaka, Takahiro Karasuno, et al.. (2020). Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation. International Journal of Hematology. 113(2). 290–296. 6 indexed citations

11.

Koizumi, Yusuke, Ken‐Ichi Imadome, Yasunori Ota, et al.. (2018). Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology. 38(4). 478–483. 11 indexed citations

12.

Imadome, Ken‐Ichi, Shinobu Tamura, Shogo Murata, et al.. (2017). An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome. Leukemia Research. 55. 1–5. 1 indexed citations

13.

Imadome, Ken‐Ichi, Mayumi Yoshimori, Yasunori Saitoh, et al.. (2017). EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells. PLoS ONE. 12(3). e0174136–e0174136. 47 indexed citations

14.

Shiratsuchi, Motoaki, Takamitsu Matsushima, Yasuhiro Tsukamoto, et al.. (2016). Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia. International Journal of Hematology. 105(4). 540–544. 5 indexed citations

15.

Liao, Huanan, Jung‐Hyun Lee, Ken‐Ichi Imadome, et al.. (2013). The highly conserved human cytomegalovirus UL136 ORF generates multiple Golgi-localizing protein isoforms through differential translation initiation. Virus Research. 179. 241–246. 4 indexed citations

16.

Yamamoto, Nobuyuki, Noriyuki Nishimura, Mai Takeuchi, et al.. (2013). The emergence of CD20−/CD19− tumor cells after rituximab therapy for Epstein–Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis. European Journal of Pediatrics. 173(12). 1615–1618. 5 indexed citations

17.

Nakamura, Hiroyuki, Huanan Liao, Kahori Minami, et al.. (2013). Human cytomegalovirus induces apoptosis in neural stem/progenitor cells derived from induced pluripotent stem cells by generating mitochondrial dysfunction and endoplasmic reticulum stress. PubMed. 4(1). 2–2. 29 indexed citations

18.

Morio, Tomohiro, N. Takahashi, Fumiaki Watanabe, et al.. (2009). Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan. International Journal of Hematology. 90(4). 455–462. 28 indexed citations

19.

Imadome, Ken‐Ichi, Norio Shimizu, Ayako Arai, et al.. (2005). Coexpression of CD40 and CD40 Ligand in Epstein‐Barr Virus–Infected T and NK Cells and Their Role in Cell Survival. The Journal of Infectious Diseases. 192(8). 1340–1348. 26 indexed citations

20.

Shirakata, Masaki, Ken‐Ichi Imadome, & Kanji Hirai. (1999). Requirement of Replication Licensing for the Dyad Symmetry Element-Dependent Replication of the Epstein–Barr Virus oriP Minichromosome. Virology. 263(1). 42–54. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact